The Role of Basal Insulin-Based Management within the Framework of ADA/EASD Guidelines for Type 2 Diabetes: A Roadmap for a Patient-Centered Approach Based on Individualizing and Integrating Basal Insulin Within a Multimodal Treatment Plan—Aligning Specific Basal Insulin Formulations with Patient Needs and Risk Factors to Optimize the Benefit-Risk Equation Charles F. Shaefer Jr., MD, FACP